Quarter Period Consolidated Statement Of Comprehensive Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7351594

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
3,914,000,000 JPY
4,377,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-448,000,000 JPY
347,000,000 JPY
Foreign currency translation adjustment
46,000,000 JPY
303,000,000 JPY
Remeasurements of defined benefit plans, net of tax
293,000,000 JPY
274,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
16,000,000 JPY
-3,000,000 JPY
Other comprehensive income
-92,000,000 JPY
922,000,000 JPY
Comprehensive income
3,821,000,000 JPY
5,300,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,821,000,000 JPY
5,300,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.